EUGENE SNYDER: Open Payments
NPI 1528330545 · TITUSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 37 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $186 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Galderma Laboratories, L.P. | 3 | $53 |
| UCB, Inc. | 2 | $35 |
| Journey Medical Corporation | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $29 |
| Lilly USA, LLC | 1 | $21 |
| GENZYME CORPORATION | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: TREMFYA, NEMLUVIO, COSENTYX, Bimzelx, LIBTAYO, Rhapsido, EBGLYSS, DUPIXENT.
Industry payments across PA — which companies pay providers there.
